Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China Medical Board, Chinese Hospital Association Pharmaceutical Specialized Committee. Expert Consensus on the Core Competency Framework of Chinese Clinical Pharmacist (2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 257-265. DOI: 10.12290/xhyxzz.2023-0092
Citation: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China Medical Board, Chinese Hospital Association Pharmaceutical Specialized Committee. Expert Consensus on the Core Competency Framework of Chinese Clinical Pharmacist (2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 257-265. DOI: 10.12290/xhyxzz.2023-0092

Expert Consensus on the Core Competency Framework of Chinese Clinical Pharmacist (2023)

Funds: 

China Medical Board Grant Funds 21-398

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-059

CAMS Innovation Fund for Medical Sciences 2021-I2M-1-003

More Information
  • Corresponding authors: ZHANG Bo1, 2, E-mail: zhangbopumch@163.com
    ZHEN Jiancun3, 4, E-mail: zhenjiancun@vip.163.com
    ZHANG Shuyang2, 5, E-mail: shuyangzhang103@163.com
    1. Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
    2. State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
    3. Department of Pharmacy, Beijing Jishuitan Hospital, Beijing 100035, China
    4. Chinese Hospital Association Pharmaceutical Specialized Committee, Beijing 100035, China
    5. Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • Received Date: February 20, 2023
  • Accepted Date: February 21, 2023
  • Available Online: February 23, 2023
  • Issue Publish Date: March 29, 2023
  • In the new era of hospital pharmaceutical service transformation, higher standards and requirements are constantly put forward for clinical pharmacists to participate in patient-centered pharmaceutical professional technical services. The formulation of competency standards has become an international trend. However, research on pharmacist competency is still limited in China, and there is a lack of core competency framework for clinical pharmacists. In order to facilitate the construction of pharmacist competency, Peking Union Medical College Hospital, China Medical Board and Chinese Hospital Association Pharmaceutical Specialized Committee organized multidisciplinary experts in pharmacy, clinical medicine, education and administration to formulate Expert Consensus on the Core Competency Framework of Chinese Clinical Pharmacist (2023), which is based on domestic and foreign research results and clinical pharmacy practice in China. This specialist consensus, adopting the modified Delphi method to formulate the core competency framework of Chinese clinical pharmacist, determines six first-level item of core competencies that clinical pharmacists should have, including professionalism, knowledge and skill, patient care, communication and collaboration, teaching and lifelong learning. The six first-level items have twenty-two second-level items, which are explained in detail. This consensus can provide an important basis and exploration direction for the training and ability enhancement of clinical pharmacists in China.
  • [1]
    中华人民共和国国家卫生健康委员会. 关于加强药事管理转变药学服务模式的通知(国卫办医发〔2017〕26号)[EB/OL]. (2017-07-12)[2022-04-14]. http://www.nhc.gov.cn/yzygj/s7659/201707/b44339ebef924f038003e1b7dca492f2.shtml.
    [2]
    中华人民共和国国家卫生健康委员会. 关于加强药学服务高质量发展的意见(国卫医发〔2018〕45号)[EB/OL ]. (2018-11-26)[2022-04-14]. http://www.nhc.gov.cn/yzygj/s7659/201811/ac342952cc114bd094fec1be086d2245.shtml.
    [3]
    中华人民共和国国家卫生健康委员会. 关于印发加强医疗机构药事管理促进合理用药的意见的通知(国卫医发〔2020〕2号)[EB/OL]. (2020-02-26)[2022-04-14]. http://www.nhc.gov.cn/yzygj/s7659/202002/ea3b96d1ac094c47a1fc39cf00f3960e.shtml.
    [4]
    高一强, 闫雪莲, 梅丹, 等. 国内外医院药师胜任力研究进展[J]. 中国药师, 2021, 24: 2244-2248. DOI: 10.19962/j.cnki.issn1008-049X.2021.12.021
    [5]
    Pharmaceutical Society of Australia. National Competency Standards Framework For Pharmacists in Australia, 2016[EB/OL]. [2022-04-14]. https://my.psa.org.au/s/article/2016-Competency-Framework.
    [6]
    National Association of Pharmacy Regulatory Authorities. Professional Competencies for Canadian Pharmacists at Entry to Practice, 2014[EB/OL]. [2022-04-14]. https://www.napra.ca/publication/professional-competencies-for-canadian-pharmacists-at-entry-to-practice/.
    [7]
    Royal Pharmaceutical Society. The RPS Foundation Pharmacist Framework, 2019[EB/OL ]. [2022-04-14]. https://www.rpharms.com/resources/frameworks/founda-tion-pharmacy-framework-fpf.
    [8]
    Saseen JJ, Ripley TL, Bondi D, et al. ACCP Clinical Pharmacist Competencies[J]. Pharmacotherapy, 2017, 37: 630-636. DOI: 10.1002/phar.1923
    [9]
    International Pharmaceutical Federation. A Global Compet-ency Framework for Services Provided by Pharmacy Workforce, 2012[EB/OL ]. [2022-04-14]. https://www.fip.org.
    [10]
    中国药师协会. 药师药学服务胜任力评价标准(试行)[J]. 中国合理用药探索, 2017, 14: 1-2. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYS201709001.htm
    [11]
    中国住院医师培训精英教学医院联盟. 中国住院医师培训精英教学医院联盟住院医师核心胜任力框架共识[J]. 协和医学杂志, 2022, 13: 17-23. DOI: 10.12290/xhyxzz.2021-0755
    [12]
    曾光, 李辉. 现代流行病学方法与应用[M]. 北京: 北京医科大学, 中国协和医科大学联合出版社, 1994: 250-270.
    [13]
    全国人民代表大会常务委员会. 《中华人民共和国药品管理法》[EB/OL]. (2019-08-27)[2022-04-14]. https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20190827083801685.html.
    [14]
    国务院. 《麻醉药品和精神药品管理条例》(国务院令第442号)[EB/OL]. (2005-08-03)[2022-04-14]. https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20050803093501339.html.
    [15]
    中华人民共和国国家卫生健康委员会. 《医疗机构药事管理规定》(卫医政发〔2011〕11号)[EB/OL]. (2011-03-30)[2022-04-14]. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=51113.
    [16]
    法规司. 《处方管理办法》(卫生部令第53号)[EB/OL ]. (2007-02-14)[2022-8-30]. http://www.nhc.gov.cn/fzs/s3576/201808/d71d4735f6c842158d2757fbaa553b80.shtml.
    [17]
    中华人民共和国国家卫生健康委员会. 国家卫生健康委办公厅关于印发医疗机构药学门诊服务规范等5项规范的通知(国卫办医函〔2021〕520号)[EB/OL]. (2021-10-13)[2022-04-14]. http://www.nhc.gov.cn/yzygj/s7659/202110/f76fc77acd87458f950c86d7bc468f22.shtml.
    [18]
    Zhao Q, Xu XY, Zhang JH. Research on the construction of a pharmacist competency model in China[J]. J Chin Pharm Sci, 2016, 25: 846-854.
    [19]
    赵玉沛. 弘扬协和优良传统培养优秀医学人才[J]. 学位与研究生教育, 2015(1): 30-31. https://www.cnki.com.cn/Article/CJFDTOTAL-XWYY201501017.htm
    [20]
    中华人民共和国国家卫生健康委员会. 关于印发《医院处方点评管理规范(试行)》的通知(卫医管发〔2010〕28号)[EB/OL]. (2010-2-10)[2022-08-30]. http://www.nhc.gov.cn/wjw/ywfw/201306/094ebc83dddc47b5a4a63ebde7224615.shtml.
    [21]
    荣春蕾, 陈鹏举, 管鸽, 等. LBL-CBL/PBL/RISE交叉教学法用于心内科临床药师培训的探索[J]. 中国合理用药探索, 2019, 16: 195-198. DOI: 10.3969/j.issn.2096-3327.2019.10.061
    [22]
    王婧雯, 王磊, 乔逸, 等. 基于临床问题的Seminar教学法在临床药师培训中的应用[J]. 中国药师, 2016, 19: 2380-2383. DOI: 10.3969/j.issn.1008-049X.2016.12.059
    [23]
    司延斌, 赵志刚. 客观结构化临床考核在药师实践技能培训中的应用[C]. 2016年北京药学年会论文集, 2016: 1-4.
    [24]
    高晨, 田德蔷. Mini-CEX应用于医院药师技能培训考核的方案设计[J]. 中国药房, 2014, 25: 3924-3927. DOI: 10.6039/j.issn.1001-0408.2014.41.29
    [25]
    孟晓晖, 张瑛, 余春辉. 柯氏和CIPP模型评价临床药师培训效果的研究[J]. 中国医院用药评价与分析, 2015, 15: 263-266. DOI: 10.14009/j.issn.1672-2124.2015.02.040
    [26]
    Yi ZM, Zhou LY, Yang L, et al. Effect of the international pharmacy education programs: A pilot evaluation based on Kirkpatrick's model[J]. Medicine (Baltimore), 2020, 99: e20945. DOI: 10.1097/MD.0000000000020945
  • Related Articles

    [1]DONG Kaixuan, ZHENG Ya, WANG Yuping, GUO Qinghong. Mechanism of SIRT2 in Metabolic Dysfunction-associated Steatotic Liver Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1382-1388. DOI: 10.12290/xhyxzz.2024-0103
    [2]DONG Kaixuan, CHEN Danni, ZHENG Ya, WANG Yuping, GUO Qinghong. The Role of CEACAM1 in Metabolic Dysfunction-associated Steatotic Liver Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1117-1123. DOI: 10.12290/xhyxzz.2024-0035
    [3]ZHANG Lu, LI Jian. Castleman Disease in China: State-of-the-art Technology Before the Era of IL-6 Targeted Therapy[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 911-914. DOI: 10.12290/xhyxzz.2023-0227
    [4]LUO Xin, PANG Kun, CHEN Jianxiong, WANG Hongzhe, XU Xinjie, LI Bing, JIA Xinmiao, YOU Xin. Differences of Intestinal Flora in Children with Autism Spectrum Disorder with Different Levels of Serum Total 25-hydroxyvitamin D[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 812-820. DOI: 10.12290/xhyxzz.2022-0254
    [5]HUANG Feiling, LIU Yanping, HE Yuan, MA Liangkun. Research Progress on Vitamin D and Gestational Diabetes Mellitus[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 994-998. DOI: 10.12290/xhyxzz.2021-0048
    [6]Zhao-liang WANG, Wen-ling ZHANG, Tao HUANG, Jia-quan GUO. Value of Dynamic Combined Monitoring of Serum Amyloid A Protein, Soluble Triggering Receptor Expressed on Myeloid Cell-1, and D-Dimer in Evaluating the Prognosis of Patients with Sepsis:A Prospective Nested Case-control Study[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 34-39. DOI: 10.3969/j.issn.1674-9081.20190051
    [7]Lin-xia WANG, Na SU, Ning-ning GUO, Guo-xin BAI, Yun-na ZHANG, Xiao-peng ZHAO, Gui-mei JI, Fang GAO, Guang-ya WANG, Jin-xiu XU, Rui-xin GAO. Correlation of 25-hydroxy Vitamin D and Lipoprotein-associated Phospholipase A2 with Diabetic Retinopathy: A Single-center Retrospective Study[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 143-147. DOI: 10.3969/j.issn.1674-9081.2019.02.011
    [8]Chenchen Fan, Fengzhi Feng, Yang Xiang, Xirun Wan, Junjun Yang, Jun Zhao, Tong Ren. Pulsed Actinomycin D for the Treatment of Low-risk Gestational Trophoblastic Neoplasia[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(1): 25-29. DOI: 10.3969/j.issn.1674-9081.2017.01.006
    [9]Yanping Liu, Qiaer Jin, Yuanyuan Bao, Shanshan Li, Shonglin Yu, Ling Qiu. Vitamin D Nutritional Status and Its Influencing Factors among Women with GestationalDiabetes Mellitus in Mid- to Late-gestation[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(1): 20-24. DOI: 10.3969/j.issn.1674-9081.2017.01.005
  • Cited by

    Periodical cited type(4)

    1. 窦紫岩,钱文红,孔邻润,陈晔,李明亮,张静波. 非酒精性脂肪性肝病检出率现状及其影响因素:基于北京市32万人群数据. 中国全科医学. 2024(02): 144-149+155 .
    2. 王伟,缪海江,王新宇. 木香流气饮联合多烯磷脂酰胆碱胶囊对非酒精性脂肪肝肝郁脾虚证患者的效果观察. 深圳中西医结合杂志. 2024(06): 46-49 .
    3. 韩炜,宋叶君,张改萍,田晓英,付素芳,赵芳,王俊,周冉,张思宇,杜金星. 非酒精性脂肪肝病人健康减重的证据总结. 全科护理. 2024(23): 4450-4453 .
    4. 吴风,孔丽蕊,谭志群. 2型糖尿病合并NAFLD患者铁蛋白、TyG-BMI变化及与脂肪变性程度的相关性. 新疆医科大学学报. 2023(10): 1338-1343 .

    Other cited types(2)

Catalog

    Article Metrics

    Article views (2361) PDF downloads (1729) Cited by(6)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close